A Danish study reveals a significant link between low-dose aspirin use and higher anemia rates among older adults.

The problems for Bayer, the maker of Aspirin, looked set to continue in 2025 with chief financial officer Wolfgang Nickl warning of a “muted outlook” next year, “with likely declining ...